Brochure
7 Sep 2026
Highly Active Pharmaceutical Ingredients (APIs)
PDF 908 kB
Heraeus Precious Metals specializes in manufacturinggeneric highly active pharmaceutical ingredients (APIs) with a focus on platinum-based APIs used in cancertreatment. With over 35 years of US FDA approval and astrong track record with major health authorities worldwide,we are recognized globally for our commitment to highquality APIs.
This brochure provides an overview of Pharmaceutical Ingredients at Heraeus Precious Metals, including our API portfolio, quality services, and key capabilities.
Content provided by our supplier
Heraeus Precious Metals GmbH & Co. KG
.png)
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Other Content from Heraeus Precious Metals GmbH & Co. KG (2)
-
News White Paper | Platinum Market Dynamics and Their Impact on Cancer Treatment Costs
Platinum-based chemotherapy drugs such as cisplatin, carboplatin, and oxaliplatin remain essential to cancer treatment worldwide. Because these APIs contain significant amounts of platinum, their cost structure is directly influenced by fluctuations in platinum prices. -
Brochure Precious Metal Catalysts for the Fine Chemical, Pharmaceutical and Agrochemical Industry
Heraeus Precious Metals offers a comprehensive range of homogeneous and heterogeneous precious metal catalysts that are characterized by high activity, selectivity and recyclability. This makes them the perfect tool for carrying out complex syntheses, e.g. for the production of active ingredients under low pressure and at low temperature, which nevertheless enable high yields.